News

Switzerland-based pharmaceutical company Synosia Therapeutics has entered into a second agreement with Roche, pursuant to which, Synosia gains access to a new-generation 5-HT6 antagonist in Phase I to

This contract allows any branch of the Department of Defense, Veterans Administration Medical Centers or government agencies to purchase directly from Swissray. With exercisable option years the contract

Mr Rosen will continue in his position with Fresenius Medical Care for the time necessary to ensure a smooth transition of the CFO responsibilities. Mr Rosen has been

Human Genome Sciences, a biopharmaceutical company, has announced that Albuferon met its primary endpoint of non-inferiority to peginterferon alfa-2a in Achieve 1, a Phase III clinical trial of

Under the contract, LCA will place Allegretto Wave Eye-Q 400Hz excimer lasers in all of the company’s 75 LasikPlus vision surgery centers by the end of the third

The European Commission decision, based on a favorable opinion from the European Medicines Agency, follows the designation of KNS-760704 as an orphan drug for the treatment of amyotrophic

The results of Phase I studies are expected to be available in April 2009. Based on these and other results, Avineuro Pharmaceuticals plans to advance AVN-211 into Phase

Under the terms of the agreement, the Israeli Ministry of Health will fund all costs associated with development of the antiserum and the establishment of a GMP manufacturing

Mr Phillippe will assume the position of CFO from Alexander Krantz, who has served as CFO since October 23, 2006. Mr Krantz will continue to act as president,